LEITAT at the first Health thematic event – Vision2020 network
10 Sep 14
LEITAT attended the first meeting of Vision 2020 Health Cluster at KU Leuven. The 2-days event aimed at discussing priorities
LEITAT attended the first meeting of Vision 2020 Health Cluster at KU Leuven. The 2-days event aimed at discussing priorities
According to the new release of Health-EU newsletter, since March the Commission has invested more than 11.9 million Euros in
The European IPR Helpdesk has published «Your Guide to IP in Horizon 2020». The purpose of this guide is to
MERMAIDS Mitigation of microplastics impact caused by textile washing processes life-mermaids.eu ABSTRACT The main objective of the project is to
LEITAT, along with all the partners of the MERMAIDS project, met at the Italian National Research Council (CNR) in Pozzuoli
Last February, Bart Bosveld, executive director of the Society of Environmental Toxicology and Chemistry (SETAC) – Europe, visited LEITAT alongside
To celebrate REWAGEN’s 2 years anniversary, the promotional video has been released. REWAGEN partners are jointly developing a wastewater treatment
Last 18th of June the EU Commission published the main funding scheme for Environmental projects. The total budget for this
TTPPP Application of the Transmembrane Therapeutic Protein Production Platform (TTPPP) to an innovative approach for the Treatment of Cancer or
NEQAM Development and Application of new Chemometric Strategies for Metabolomic Analysis ABSTRACT NEQAM project aims at the development, assessment and
ACINETOCLINIC Transition to Clinical Investigation Phase for Licencing of the First Vaccine Against Drug Resistent Acinetobacter Baumannii ABSTRACT Vaccines against
IDP4MM Development of drugs in new therapeutic IDP targets for the treatment of multiple myeloma ABSTRACT This project is part
The EC e-magazine CORDIS Express has devoted its latest issue to looking at a range of 8 research projects focused
TOXAB Development of Novel, Safe and Affordable Cytotoxic Antibodies for the Treatment of Cancer ABSTRACT The main objective of the
NUEVAS DIANAS Discovery and combination of new treatments for cancer treatment based on the modulation of epigenetic targets and adenosine
MICROALMABS Validation of a New Platform for Production of Therapeutic Monoclonal Antibodies with Microalgae ABSTRACT The objective of the present
Sede Central Leitat
C/ de la Innovació, 2
08225 Terrassa, (Barcelona)
Tel. (+34) 937 882 300
